Annual Total Long Term Liabilities
$304.67 M
-$44.90 M-12.84%
31 December 2023
Summary:
Foghorn Therapeutics annual total long term liabilities is currently $304.67 million, with the most recent change of -$44.90 million (-12.84%) on 31 December 2023. During the last 3 years, it has risen by +$214.11 million (+236.43%). FHTX annual total long term liabilities is now -18.58% below its all-time high of $374.21 million, reached on 31 December 2021.FHTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$279.83 M
-$12.20 M-4.18%
30 September 2024
Summary:
Foghorn Therapeutics quarterly total long term liabilities is currently $279.83 million, with the most recent change of -$12.20 million (-4.18%) on 30 September 2024. Over the past year, it has dropped by -$38.96 million (-12.22%). FHTX quarterly long term liabilities is now -25.22% below its all-time high of $374.21 million, reached on 31 December 2021.FHTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.8% | -12.2% |
| 3 y3 years | +236.4% | +226.2% |
| 5 y5 years | +286.3% | - |
FHTX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.6% | +236.4% | -25.2% | +226.2% |
| 5 y | 5 years | -18.6% | +286.3% | -25.2% | +363.8% |
| alltime | all time | -18.6% | +286.3% | -25.2% | +363.8% |
Foghorn Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $279.83 M(-4.2%) |
| June 2024 | - | $292.04 M(-2.8%) |
| Mar 2024 | - | $300.43 M(-1.4%) |
| Dec 2023 | $304.67 M(-12.8%) | $304.67 M(-4.4%) |
| Sept 2023 | - | $318.80 M(-4.1%) |
| June 2023 | - | $332.29 M(-2.7%) |
| Mar 2023 | - | $341.67 M(-2.3%) |
| Dec 2022 | $349.57 M | $349.57 M(-1.4%) |
| Sept 2022 | - | $354.40 M(-1.9%) |
| June 2022 | - | $361.30 M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $367.66 M(-1.8%) |
| Dec 2021 | $374.21 M(+313.2%) | $374.21 M(+336.2%) |
| Sept 2021 | - | $85.79 M(-2.4%) |
| June 2021 | - | $87.92 M(-0.5%) |
| Mar 2021 | - | $88.39 M(-2.4%) |
| Dec 2020 | $90.56 M(-7.3%) | $90.56 M(-64.4%) |
| Sept 2020 | - | $254.45 M(+321.7%) |
| June 2020 | - | $60.34 M(-38.2%) |
| Dec 2019 | $97.71 M(+23.9%) | $97.71 M |
| Dec 2018 | $78.87 M | - |
FAQ
- What is Foghorn Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual total long term liabilities year-on-year change?
- What is Foghorn Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly long term liabilities year-on-year change?
What is Foghorn Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FHTX is $304.67 M
What is the all time high annual total long term liabilities for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual total long term liabilities is $374.21 M
What is Foghorn Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FHTX annual total long term liabilities has changed by -$44.90 M (-12.84%)
What is Foghorn Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FHTX is $279.83 M
What is the all time high quarterly long term liabilities for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly total long term liabilities is $374.21 M
What is Foghorn Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FHTX quarterly total long term liabilities has changed by -$38.96 M (-12.22%)